UPDATE 1-Merck wins Japan approval for Gardasil vaccine

NEW YORK, July 1 (Reuters) - Merck & Co won approval in Japan to sell its Gardasil cervical cancer vaccine and two other products, the U.S. drugmaker said on Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.